The coiled-coil domain-containing protein 53 (CCDC53) is an essential protein involved in various cellular processes. This protein, characterized by the presence of coiled-coil motifs, is known to participate in complex protein-protein interactions, playing pivotal roles in the intracellular framework. Coiled-coil motifs are structural motifs in proteins where two or more alpha-helices are coiled together like the strands of a rope. Proteins with these motifs often function as scaffolds, helping to organize other proteins and facilitating complex interactions within the cell. CCDC53, being a member of the coiled-coil domain-containing protein family, is thought to be instrumental in many cellular dynamics, although the full range of its roles is still a topic of research.
CCDC53 inhibitors are molecules designed to specifically target and hinder the activity or interactions involving CCDC53. Since the protein is involved in intricate protein-protein interactions, the inhibition of CCDC53 can disrupt these interactions and, subsequently, the processes they regulate. The development of CCDC53 inhibitors often requires a profound understanding of the protein's structure, function, and interaction partners. Advanced techniques such as molecular docking, structure-based drug design, and high-throughput screening are typically employed to identify potential inhibitory compounds. Once candidates are identified, their efficacy, selectivity, and binding modes can be studied in detail, providing valuable insights into the molecular mechanisms of action. These inhibitors, while primarily serving as research tools, aid in unveiling the physiological and biochemical roles of CCDC53 in cellular processes, offering a deeper understanding of the protein's function and its implications in cellular biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $260.00 $799.00 | 36 | |
This compound binds actin monomers and prevents polymerization, potentially affecting CCDC53 as part of the WRC. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Known to inhibit actin filament elongation, which might indirectly influence CCDC53 expression. | ||||||
Swinholide A, Theonella swinhoei | 95927-67-6 | sc-205914 | 10 µg | $135.00 | ||
Disrupts actin filaments by severing them, potentially impacting WRC and CCDC53. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $180.00 $299.00 | 59 | |
Stabilizes actin filaments, potentially influencing cellular processes involving CCDC53. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
ROCK inhibitor that affects actin dynamics, potentially having an effect on CCDC53. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $179.00 $307.00 $455.00 $924.00 $1689.00 | 7 | |
Myosin II inhibitor impacting actin-myosin interactions, which might influence CCDC53. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $315.00 $1020.00 | 5 | |
An inhibitor of the Arp2/3 complex, which plays a role in actin nucleation, potentially affecting CCDC53 function. | ||||||
SMIFH2 | 340316-62-3 | sc-507273 | 5 mg | $140.00 | ||
An inhibitor of formins, which are involved in actin dynamics, and might impact CCDC53. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $134.00 $502.00 | 7 | |
An inhibitor of Cdc42, a small GTPase involved in actin polymerization, potentially affecting CCDC53. | ||||||
EHT 1864 | 754240-09-0 | sc-361175 sc-361175A | 10 mg 50 mg | $209.00 $872.00 | 12 | |
Rac family small GTPase inhibitor, potentially affecting pathways involving CCDC53. |